GHK-Cu is a naturally occurring copper-binding tripeptide composed of glycine–histidine–lysine complexed with divalent copper (Cu²⁺). Originally identified in human plasma, this small peptide functions as a high-affinity copper chelator and transporter in biological systems. In laboratory research, GHK-Cu is classified as a copper–peptide complex used to investigate cellular signaling pathways related to tissue remodeling, extracellular matrix regulation, and metal ion–mediated enzymatic activity.
Mechanistically, GHK-Cu has been shown in experimental models to influence gene expression patterns associated with collagen synthesis, extracellular matrix turnover, and growth factor modulation. By delivering bioavailable copper to target sites, it may support the activity of copper-dependent enzymes involved in antioxidant defense and connective tissue biology. Research has also examined its effects on inflammatory signaling pathways and cellular proliferation markers, making it a compound of interest in studies focused on wound repair and dermal matrix regulation.
In vitro applications commonly include evaluation of fibroblast activity, collagen and glycosaminoglycan production, and transcriptional profiling of genes associated with tissue regeneration. Preclinical investigations have also explored its impact on oxidative stress markers and metalloproteinase balance. Its small molecular size and stable copper complex facilitate controlled experimental handling and reproducible dosing conditions in laboratory environments.
Overall, GHK-Cu is regarded as a research-grade copper peptide complex widely used to probe mechanisms of extracellular matrix biology, metal ion transport, and regenerative signaling pathways. Its defined structure and established biochemical interactions make it a valuable tool for controlled laboratory investigations. It is intended strictly for research use in regulated laboratory settings.
